Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma

Published:2014-04-10 Issue:1 Volume:45 Page:97-106
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Zhu Shaojun¹^ORCID,Li Yanhong¹²,Zhang Yang³,Wang Xuxia⁴,Gong Li¹,Han Xiujuan¹,Yao Li¹,Lan Miao¹,Zhang Wei¹

Affiliation:

1. Department of Pathology; The Helmholtz Sino-German Research Laboratory for Cancer; Tangdu Hospital; the Fourth Military Medical University; Xi'an China

2. Department of Gynecology and Obstetrics; Tangdu Hospital; the Fourth Military Medical University; Xi'an China

3. Department of Gastroenterology; Tangdu Hospital; the Fourth Military Medical University; Xi'an China

4. State Key Laboratory of Cancer Biology; Cell Engineering Research Center and Department of Cell Biology; National Key Discipline of Cell Biology; the Fourth Military Medical University; Xi'an China

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12320/fullpdf

Reference47 articles.

1. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004

2. Viral hepatocarcinogenesis;Tsai;Oncogene,2010

3. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

4. Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma;Korangy;Clin Cancer Res,2004

5. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma;Ormandy;Cancer Res,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?;Cancer Treatment Reviews;2024-09

2. Relationships between CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma;2024-06-07

3. Chimeric Antigen Receptor T Cell Therapy for Hepatocellular Carcinoma: Where Do We Stand?;International Journal of Molecular Sciences;2024-02-23

4. Molecular profiling in the management of hepatocellular carcinoma;Current Opinion in Organ Transplantation;2023-12-01

5. Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework;European Journal of Medical Research;2023-08-30